Cancer: CpG–siRNA deals double blow to tumours

response and boost their own growth by inducing the expression of immunosuppressive, angiogenic and growth factors in neighbouring cells. Reporting in Nature Biotechnology, Kortylewski and colleagues now present a new strategy to alter the balance in the tumour microenvironment to re-awaken an anticancer immune response. By coupling a Tolllike receptor (TLR… CONTINUE READING